DISPOSITION OF A FLOW-LIMITED DRUG (LIDOCAINE) AND A METABOLIC CAPACITY LIMITED DRUG (THEOPHYLLINE) IN LIVER-CIRRHOSIS

被引：35

作者：

COLLI, A

BUCCINO, G

COCCIOLO, M

PARRAVICINI, R

SCALTRINI, G

机构：

来源：

关键词：

D O I：

10.1038/clpt.1988.206

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：642 / 649

页数：8

共 23 条

[1] BOLONDI L, 1984, DIAGNOSTIC ULTRASOUN, P369
[2] BOYES RN, 1971, CLIN PHARMACOL THER, V12, P105
[3] BRANCH RA, 1982, HEPATOLOGY, V2, P97
[4] Child CG, 1964, LIVER PORTAL HYPERTE, P50
[5] Conn H O, 1981, Hepatology, V1, P673, DOI 10.1002/hep.1840010617
[6] ANTIPYRINE, PARACETAMOL, AND LIGNOCAINE ELIMINATION IN CHRONIC LIVER-DISEASE
FORREST, JAH
FINLAYSON, NDC
ADJEPONYAMOAH, KK
PRESCOTT, LF
[J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6073) : 1384 - 1387
[7] GROSS G, 1975, NEW ENGL J MED, V293, P717
[8] HUET PM, 1983, HEPATOLOGY, V3, P913
[9] EFFECTS OF SMOKING AND CHRONIC HEPATITIS-B ON LIDOCAINE AND INDOCYANINE GREEN KINETICS
HUET, PM
LELORIER, J
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 208 - 215
[10] HUET PM, 1982, J CLIN INVEST, V70, P1236